| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.54 | 0.001 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.5 | 0.01 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.5 | 0.007 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.47 | 0.02 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.43 | 0.02 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.42 | 0.02 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.4 | 0.03 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.39 | 0.05 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.39 | 0.05 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.39 | 0.04 |